Clinical Trials Browser

Phase NA × orelabrutinib × 1 year × Clear all

NCT07257510 2025-12-02

Pomalidomide Plus Orelabrutinib and Zuberitamab in Untreated Mantle Cell Lymphoma

Phase NA Recruiting

Lymphoma, Mantle-Cell